Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avaxia Biologics Inc.

www.avaxiabiologics.com

Latest From Institute for Diabetes Discovery Inc.

Just Around the Corner: Pursuing the Elusive Diabetes Market

Diabetes seems like a great clinical and commercial opportunity but it's been a technological nightmare for many small device and diagnostic companies. Still, there's enough good news coming out of R&D to keep entrepreneurs going
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Avaxia Biologics Inc.
  • Senior Management
  • Barbara S Fox, PhD, CEO
    Deborah S Hartman, PhD, VP, Research
    Michael D Rivard, VP, Corp. Dev.
    Harris M. Scott, MD, CMO
    Kevin Sarney, VP, Fin. & Admin.
  • Contact Info
  • Avaxia Biologics Inc.
    Phone: (781) 861-0062
    128 Spring St.
    Ste. 620
    Lexington, MA 02421
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register